The usefulness of tau protein for predicting neurologic outcome of traumatic brain injury has been evaluated in a study enrolling 56 patients by measuring the serum level of tau serially (12h, 1d, 2d, 3d, 4d, 7d, 14d) after injury and analyzing the association with extended Glasgow outcome scale (GOSE). This evidence concerns the gene MAPT and brain injury.